Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Buy
60
AFJK Quote, Financials, Valuation and Earnings
Last price:
$36.12
Seasonality move
:
1.54%
Day range:
$36.03 - $51.50
52-week range:
$6.75 - $98.15
Dividend yield:
0%
P/E ratio:
178.81x
P/S ratio:
--
P/B ratio:
5.25x
Volume:
125.4K
Avg. volume:
318.2K
1-year change:
239.74%
Market cap:
$220.6M
Revenue:
--
EPS (TTM):
$0.20
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
AFJK
Aimei Health Technology Co., Ltd.
|
-- | -- | -- | -- | -- |
|
ATMC
AlphaTime Acquisition Corp.
|
-- | -- | -- | -- | -- |
|
CCAP
Crescent Capital BDC, Inc.
|
$39.5M | $0.41 | -9.28% | 59.5% | $16.08 |
|
GRAF
Graf Global Corp.
|
-- | -- | -- | -- | -- |
|
LEGT
Legato Merger Corp. III
|
-- | -- | -- | -- | -- |
|
TBMC
Trailblazer Merger Corp. I
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
AFJK
Aimei Health Technology Co., Ltd.
|
$36.03 | -- | $220.6M | 178.81x | $0.00 | 0% | -- |
|
ATMC
AlphaTime Acquisition Corp.
|
$15.60 | -- | $39.8M | 152.05x | $0.00 | 0% | -- |
|
CCAP
Crescent Capital BDC, Inc.
|
$14.65 | $16.08 | $541.9M | 15.08x | $0.42 | 11.47% | 3.48x |
|
GRAF
Graf Global Corp.
|
$10.72 | -- | $308.2M | 35.56x | $0.00 | 0% | -- |
|
LEGT
Legato Merger Corp. III
|
$10.86 | -- | $280.1M | 32.80x | $0.00 | 0% | -- |
|
TBMC
Trailblazer Merger Corp. I
|
$12.00 | -- | $29.4M | 266.34x | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
AFJK
Aimei Health Technology Co., Ltd.
|
3.79% | 0.037 | 2.39% | 0.00x |
|
ATMC
AlphaTime Acquisition Corp.
|
11.55% | 0.256 | 3.42% | 0.00x |
|
CCAP
Crescent Capital BDC, Inc.
|
55.07% | 0.090 | 168.67% | 3.38x |
|
GRAF
Graf Global Corp.
|
-- | 0.022 | -- | 0.00x |
|
LEGT
Legato Merger Corp. III
|
-- | -0.016 | -- | -- |
|
TBMC
Trailblazer Merger Corp. I
|
-1177.47% | -0.094 | 25.81% | 0.70x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
AFJK
Aimei Health Technology Co., Ltd.
|
-- | -$130.2K | 2.58% | 2.61% | -- | -$96.1K |
|
ATMC
AlphaTime Acquisition Corp.
|
-- | $1.5K | 2.28% | 2.45% | -- | $60.9K |
|
CCAP
Crescent Capital BDC, Inc.
|
$27.8M | $21.4M | 2.24% | 4.93% | 58.62% | $18.7M |
|
GRAF
Graf Global Corp.
|
-- | -$798.2K | 3.79% | 3.79% | -- | -$106.5K |
|
LEGT
Legato Merger Corp. III
|
-- | -$269.1K | 4.1% | 4.1% | -- | -$212.1K |
|
TBMC
Trailblazer Merger Corp. I
|
-- | -$563.8K | -26.31% | -32.93% | -- | -$1.4M |
Aimei Health Technology Co., Ltd. vs. Competitors
-
Which has Higher Returns AFJK or ATMC?
AlphaTime Acquisition Corp. has a net margin of -- compared to Aimei Health Technology Co., Ltd.'s net margin of --. Aimei Health Technology Co., Ltd.'s return on equity of 2.61% beat AlphaTime Acquisition Corp.'s return on equity of 2.45%.
Company Gross Margin Earnings Per Share Invested Capital AFJKAimei Health Technology Co., Ltd.-- $0.06 $43.7M ATMCAlphaTime Acquisition Corp.-- $0.06 $13.3M -
What do Analysts Say About AFJK or ATMC?
Aimei Health Technology Co., Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand AlphaTime Acquisition Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Aimei Health Technology Co., Ltd. has higher upside potential than AlphaTime Acquisition Corp., analysts believe Aimei Health Technology Co., Ltd. is more attractive than AlphaTime Acquisition Corp..
Company Buy Ratings Hold Ratings Sell Ratings AFJKAimei Health Technology Co., Ltd.0 0 0 ATMCAlphaTime Acquisition Corp.0 0 0 -
Is AFJK or ATMC More Risky?
Aimei Health Technology Co., Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison AlphaTime Acquisition Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock AFJK or ATMC?
Aimei Health Technology Co., Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AlphaTime Acquisition Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aimei Health Technology Co., Ltd. pays -- of its earnings as a dividend. AlphaTime Acquisition Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AFJK or ATMC?
Aimei Health Technology Co., Ltd. quarterly revenues are --, which are smaller than AlphaTime Acquisition Corp. quarterly revenues of --. Aimei Health Technology Co., Ltd.'s net income of $352K is higher than AlphaTime Acquisition Corp.'s net income of $202.1K. Notably, Aimei Health Technology Co., Ltd.'s price-to-earnings ratio is 178.81x while AlphaTime Acquisition Corp.'s PE ratio is 152.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aimei Health Technology Co., Ltd. is -- versus -- for AlphaTime Acquisition Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AFJKAimei Health Technology Co., Ltd.-- 178.81x -- $352K ATMCAlphaTime Acquisition Corp.-- 152.05x -- $202.1K
-
Which has Higher Returns AFJK or CCAP?
Crescent Capital BDC, Inc. has a net margin of -- compared to Aimei Health Technology Co., Ltd.'s net margin of 19.49%. Aimei Health Technology Co., Ltd.'s return on equity of 2.61% beat Crescent Capital BDC, Inc.'s return on equity of 4.93%.
Company Gross Margin Earnings Per Share Invested Capital AFJKAimei Health Technology Co., Ltd.-- $0.06 $43.7M CCAPCrescent Capital BDC, Inc.76.15% $0.19 $1.6B -
What do Analysts Say About AFJK or CCAP?
Aimei Health Technology Co., Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Crescent Capital BDC, Inc. has an analysts' consensus of $16.08 which suggests that it could grow by 9.78%. Given that Crescent Capital BDC, Inc. has higher upside potential than Aimei Health Technology Co., Ltd., analysts believe Crescent Capital BDC, Inc. is more attractive than Aimei Health Technology Co., Ltd..
Company Buy Ratings Hold Ratings Sell Ratings AFJKAimei Health Technology Co., Ltd.0 0 0 CCAPCrescent Capital BDC, Inc.3 1 0 -
Is AFJK or CCAP More Risky?
Aimei Health Technology Co., Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Crescent Capital BDC, Inc. has a beta of 0.559, suggesting its less volatile than the S&P 500 by 44.06%.
-
Which is a Better Dividend Stock AFJK or CCAP?
Aimei Health Technology Co., Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Crescent Capital BDC, Inc. offers a yield of 11.47% to investors and pays a quarterly dividend of $0.42 per share. Aimei Health Technology Co., Ltd. pays -- of its earnings as a dividend. Crescent Capital BDC, Inc. pays out 84.04% of its earnings as a dividend. Crescent Capital BDC, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios AFJK or CCAP?
Aimei Health Technology Co., Ltd. quarterly revenues are --, which are smaller than Crescent Capital BDC, Inc. quarterly revenues of $36.4M. Aimei Health Technology Co., Ltd.'s net income of $352K is lower than Crescent Capital BDC, Inc.'s net income of $7.1M. Notably, Aimei Health Technology Co., Ltd.'s price-to-earnings ratio is 178.81x while Crescent Capital BDC, Inc.'s PE ratio is 15.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aimei Health Technology Co., Ltd. is -- versus 3.48x for Crescent Capital BDC, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AFJKAimei Health Technology Co., Ltd.-- 178.81x -- $352K CCAPCrescent Capital BDC, Inc.3.48x 15.08x $36.4M $7.1M
-
Which has Higher Returns AFJK or GRAF?
Graf Global Corp. has a net margin of -- compared to Aimei Health Technology Co., Ltd.'s net margin of --. Aimei Health Technology Co., Ltd.'s return on equity of 2.61% beat Graf Global Corp.'s return on equity of 3.79%.
Company Gross Margin Earnings Per Share Invested Capital AFJKAimei Health Technology Co., Ltd.-- $0.06 $43.7M GRAFGraf Global Corp.-- $0.06 $232.8M -
What do Analysts Say About AFJK or GRAF?
Aimei Health Technology Co., Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Graf Global Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Aimei Health Technology Co., Ltd. has higher upside potential than Graf Global Corp., analysts believe Aimei Health Technology Co., Ltd. is more attractive than Graf Global Corp..
Company Buy Ratings Hold Ratings Sell Ratings AFJKAimei Health Technology Co., Ltd.0 0 0 GRAFGraf Global Corp.0 0 0 -
Is AFJK or GRAF More Risky?
Aimei Health Technology Co., Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Graf Global Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock AFJK or GRAF?
Aimei Health Technology Co., Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Graf Global Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aimei Health Technology Co., Ltd. pays -- of its earnings as a dividend. Graf Global Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AFJK or GRAF?
Aimei Health Technology Co., Ltd. quarterly revenues are --, which are smaller than Graf Global Corp. quarterly revenues of --. Aimei Health Technology Co., Ltd.'s net income of $352K is lower than Graf Global Corp.'s net income of $1.7M. Notably, Aimei Health Technology Co., Ltd.'s price-to-earnings ratio is 178.81x while Graf Global Corp.'s PE ratio is 35.56x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aimei Health Technology Co., Ltd. is -- versus -- for Graf Global Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AFJKAimei Health Technology Co., Ltd.-- 178.81x -- $352K GRAFGraf Global Corp.-- 35.56x -- $1.7M
-
Which has Higher Returns AFJK or LEGT?
Legato Merger Corp. III has a net margin of -- compared to Aimei Health Technology Co., Ltd.'s net margin of --. Aimei Health Technology Co., Ltd.'s return on equity of 2.61% beat Legato Merger Corp. III's return on equity of 4.1%.
Company Gross Margin Earnings Per Share Invested Capital AFJKAimei Health Technology Co., Ltd.-- $0.06 $43.7M LEGTLegato Merger Corp. III-- $0.08 $210.9M -
What do Analysts Say About AFJK or LEGT?
Aimei Health Technology Co., Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Legato Merger Corp. III has an analysts' consensus of -- which suggests that it could fall by --. Given that Aimei Health Technology Co., Ltd. has higher upside potential than Legato Merger Corp. III, analysts believe Aimei Health Technology Co., Ltd. is more attractive than Legato Merger Corp. III.
Company Buy Ratings Hold Ratings Sell Ratings AFJKAimei Health Technology Co., Ltd.0 0 0 LEGTLegato Merger Corp. III0 0 0 -
Is AFJK or LEGT More Risky?
Aimei Health Technology Co., Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Legato Merger Corp. III has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock AFJK or LEGT?
Aimei Health Technology Co., Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Legato Merger Corp. III offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aimei Health Technology Co., Ltd. pays -- of its earnings as a dividend. Legato Merger Corp. III pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AFJK or LEGT?
Aimei Health Technology Co., Ltd. quarterly revenues are --, which are smaller than Legato Merger Corp. III quarterly revenues of --. Aimei Health Technology Co., Ltd.'s net income of $352K is lower than Legato Merger Corp. III's net income of $2M. Notably, Aimei Health Technology Co., Ltd.'s price-to-earnings ratio is 178.81x while Legato Merger Corp. III's PE ratio is 32.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aimei Health Technology Co., Ltd. is -- versus -- for Legato Merger Corp. III. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AFJKAimei Health Technology Co., Ltd.-- 178.81x -- $352K LEGTLegato Merger Corp. III-- 32.80x -- $2M
-
Which has Higher Returns AFJK or TBMC?
Trailblazer Merger Corp. I has a net margin of -- compared to Aimei Health Technology Co., Ltd.'s net margin of --. Aimei Health Technology Co., Ltd.'s return on equity of 2.61% beat Trailblazer Merger Corp. I's return on equity of -32.93%.
Company Gross Margin Earnings Per Share Invested Capital AFJKAimei Health Technology Co., Ltd.-- $0.06 $43.7M TBMCTrailblazer Merger Corp. I-- -$0.82 -$627.9K -
What do Analysts Say About AFJK or TBMC?
Aimei Health Technology Co., Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Trailblazer Merger Corp. I has an analysts' consensus of -- which suggests that it could fall by --. Given that Aimei Health Technology Co., Ltd. has higher upside potential than Trailblazer Merger Corp. I, analysts believe Aimei Health Technology Co., Ltd. is more attractive than Trailblazer Merger Corp. I.
Company Buy Ratings Hold Ratings Sell Ratings AFJKAimei Health Technology Co., Ltd.0 0 0 TBMCTrailblazer Merger Corp. I0 0 0 -
Is AFJK or TBMC More Risky?
Aimei Health Technology Co., Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Trailblazer Merger Corp. I has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock AFJK or TBMC?
Aimei Health Technology Co., Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Trailblazer Merger Corp. I offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aimei Health Technology Co., Ltd. pays -- of its earnings as a dividend. Trailblazer Merger Corp. I pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AFJK or TBMC?
Aimei Health Technology Co., Ltd. quarterly revenues are --, which are smaller than Trailblazer Merger Corp. I quarterly revenues of --. Aimei Health Technology Co., Ltd.'s net income of $352K is higher than Trailblazer Merger Corp. I's net income of -$3.7M. Notably, Aimei Health Technology Co., Ltd.'s price-to-earnings ratio is 178.81x while Trailblazer Merger Corp. I's PE ratio is 266.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aimei Health Technology Co., Ltd. is -- versus -- for Trailblazer Merger Corp. I. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AFJKAimei Health Technology Co., Ltd.-- 178.81x -- $352K TBMCTrailblazer Merger Corp. I-- 266.34x -- -$3.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
